Comparative statistics by cancer registry
Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site
(Kampala, Uganda, 1993-1997 cases followed-up until 1999)Click on cancer site (ICD-10 code) for comparison
| % | No. of excluded cases | Included cases | |||||||||
| Site | ICD-10 | Total registered | HV | DCO | DCO | No. follow-up | Others | Total | % | No. | % |
| C11 | Nasopharynx | 63 | 77.8 | 0.0 | 0 | 14 | 0 | 14 | 22.2 | 49 | 77.8 |
| C15 | Oesophagus | 196 | 40.3 | 0.0 | 0 | 14 | 2 | 16 | 8.2 | 180 | 91.8 |
| C16 | Stomach | 104 | 48.1 | 0.0 | 0 | 11 | 3 | 14 | 13.5 | 90 | 86.5 |
| C18 | Colon | 56 | 57.1 | 0.0 | 0 | 4 | 1 | 5 | 8.9 | 51 | 91.1 |
| C19-20 | Rectum | 59 | 67.8 | 0.0 | 0 | 8 | 1 | 9 | 15.3 | 50 | 84.7 |
| C22 | Liver | 133 | 36.1 | 0.8 | 1 | 8 | 8 | 17 | 12.8 | 116 | 87.2 |
| C33-34 | Lung | 55 | 61.8 | 1.8 | 1 | 3 | 4 | 8 | 14.5 | 47 | 85.5 |
| C46 | Kaposi sarcoma | 431 | 80.5 | 0.0 | 0 | 60 | 1 | 61 | 14.2 | 370 | 85.8 |
| C50 | Breast | 233 | 63.9 | 0.0 | 0 | 66 | 5 | 71 | 30.5 | 162 | 69.5 |
| C53 | Cervix | 461 | 63.8 | 0.2 | 1 | 166 | 11 | 178 | 38.6 | 283 | 61.4 |
| C56 | Ovary | 75 | 54.7 | 0.0 | 0 | 9 | 0 | 9 | 12.0 | 66 | 88.0 |
| C61 | Prostate | 213 | 76.5 | 0.0 | 0 | 40 | 19 | 59 | 27.7 | 154 | 72.3 |
| C69 | Eye | 140 | 66.4 | 0.0 | 0 | 55 | 4 | 59 | 42.1 | 81 | 57.9 |
| C73 | Thyroid | 53 | 83.0 | 0.0 | 0 | 11 | 3 | 14 | 26.4 | 39 | 73.6 |
| C82-85+C96 | Non-Hodgkin lymphoma | 251 | 79.7 | 0.8 | 2 | 69 | 2 | 73 | 29.1 | 178 | 70.9 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
| - Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Kampala, Uganda, 1993-1997 cases followed-up until 1999) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |